Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 18:24
Neurocrine Biosciences Max Drawdown (5Y) : 46.39% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 46.39% |
| June 30, 2026 | 46.39% |
| May 31, 2026 | 46.39% |
| April 30, 2026 | 46.39% |
| March 31, 2026 | 46.39% |
| February 28, 2026 | 46.39% |
| January 31, 2026 | 46.39% |
| December 31, 2025 | 46.39% |
| November 30, 2025 | 46.39% |
| October 31, 2025 | 46.39% |
| September 30, 2025 | 46.39% |
| August 31, 2025 | 46.39% |
| July 31, 2025 | 46.39% |
| June 30, 2025 | 46.39% |
| May 31, 2025 | 46.39% |
| April 30, 2025 | 46.39% |
| March 31, 2025 | 46.39% |
| February 28, 2025 | 46.39% |
| January 31, 2025 | 46.39% |
| December 31, 2024 | 46.39% |
| November 30, 2024 | 46.39% |
| October 31, 2024 | 46.39% |
| September 30, 2024 | 46.39% |
| August 31, 2024 | 46.39% |
| July 31, 2024 | 46.39% |
| Date | Value |
|---|---|
| June 30, 2024 | 46.39% |
| May 31, 2024 | 46.39% |
| April 30, 2024 | 46.39% |
| March 31, 2024 | 46.39% |
| February 29, 2024 | 46.39% |
| January 31, 2024 | 46.39% |
| December 31, 2023 | 46.39% |
| November 30, 2023 | 46.39% |
| October 31, 2023 | 46.39% |
| September 30, 2023 | 46.39% |
| August 31, 2023 | 46.39% |
| July 31, 2023 | 46.39% |
| June 30, 2023 | 46.39% |
| May 31, 2023 | 46.39% |
| April 30, 2023 | 46.39% |
| March 31, 2023 | 46.39% |
| February 28, 2023 | 46.39% |
| January 31, 2023 | 46.39% |
| December 31, 2022 | 46.39% |
| November 30, 2022 | 46.39% |
| October 31, 2022 | 46.39% |
| September 30, 2022 | 46.39% |
| August 31, 2022 | 46.39% |
| July 31, 2022 | 46.39% |
| June 30, 2022 | 46.39% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Amarin Corp. Plc | 98.07% |
| Liquidia Corp. | 93.87% |
| Incyte Corp. | 58.51% |
| Krystal Biotech, Inc. | 53.42% |
| Halozyme Therapeutics, Inc. | 49.06% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.068 |
| Beta (5Y) | 0.3933 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 30.88% |
| Historical Sharpe Ratio (5Y) | 0.2813 |
| Historical Sortino (5Y) | 0.4345 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.26% |